Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Schweizerische Medizinische Wochenschrift
|
November 2, 2001
[Cost effectiveness in treatment of acute myeloid leukemia]
P Nordmann, A Schaffner, H Dazzi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zürich, Switzerland, between 1990 and 1996
H Dazzi, K Kaufmann, F Follath
International Pharmacopsychiatry
|
January 1, 1982
Rebound phenomena: results of a 10 years' (1970--1980) literature review
R Lupolover, H Dazzi, J Ward
Schweizerische Medizinische Wochenschrift
|
June 25, 1994
[Meningitis in adults]
H Dazzi, B Risti, C Ruef
Dermatology (Basel, Switzerland)
|
January 1, 1992
Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphomas of the skin
R G Panizzon, R Speich, H Dazzi
Respiration; International Review of Thoracic Diseases
|
January 1, 1996
Septic pulmonary embolism due to periodontal disease in a patient with hereditary hemorrhagic telangiectasia
E W Russi, H Dazzi, N Gäumann
Schweizerische Medizinische Wochenschrift
|
March 4, 1995
[Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia]
E O Meili, H Dazzi, A von Felten
Respiratory Medicine
|
May 1, 1990
DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival
H Dazzi, N Thatcher, P S Hasleton, et al.
International Journal of Cancer
|
March 15, 1989
Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2
A K Ghosh, H Dazzi, N Thatcher, et al.
Cancer Treatment Reviews
|
June 1, 1989
Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II study
N Thatcher, H Dazzi, A Gosh, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Schweizerische Medizinische Wochenschrift
|
November 2, 2001
[Cost effectiveness in treatment of acute myeloid leukemia]
P Nordmann, A Schaffner, H Dazzi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zürich, Switzerland, between 1990 and 1996
H Dazzi, K Kaufmann, F Follath
International Pharmacopsychiatry
|
January 1, 1982
Rebound phenomena: results of a 10 years' (1970--1980) literature review
R Lupolover, H Dazzi, J Ward
Schweizerische Medizinische Wochenschrift
|
June 25, 1994
[Meningitis in adults]
H Dazzi, B Risti, C Ruef
Dermatology (Basel, Switzerland)
|
January 1, 1992
Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphomas of the skin
R G Panizzon, R Speich, H Dazzi
Respiration; International Review of Thoracic Diseases
|
January 1, 1996
Septic pulmonary embolism due to periodontal disease in a patient with hereditary hemorrhagic telangiectasia
E W Russi, H Dazzi, N Gäumann
Schweizerische Medizinische Wochenschrift
|
March 4, 1995
[Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia]
E O Meili, H Dazzi, A von Felten
Respiratory Medicine
|
May 1, 1990
DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival
H Dazzi, N Thatcher, P S Hasleton, et al.
International Journal of Cancer
|
March 15, 1989
Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2
A K Ghosh, H Dazzi, N Thatcher, et al.
Cancer Treatment Reviews
|
June 1, 1989
Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II study
N Thatcher, H Dazzi, A Gosh, et al.
Page
of 3